SEC Filings | BioLineRx

Filing Date	Form	Description	View
Feb 27, 2020	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-20-000666.rtf 0001178913-20-000666.pdf
Feb 19, 2020	CT ORDER	CT ORDER	9999999997-20-000778.pdf
Feb 14, 2020	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000921895-20-000556.rtf 0000921895-20-000556.xls 0000921895-20-000556.pdf
Feb 07, 2020	SC 13G/A	An amendment to the SC 13G filing	0000902664-20-000814.rtf 0000902664-20-000814.xls 0000902664-20-000814.pdf
Jan 30, 2020	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-20-000238.rtf 0001178913-20-000238.xls 0001178913-20-000238.pdf
Jan 22, 2020	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-20-000147.rtf 0001178913-20-000147.xls 0001178913-20-000147.pdf
Jan 14, 2020	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-20-000102.rtf 0001178913-20-000102.xls 0001178913-20-000102.pdf
Dec 13, 2019	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-19-002920.rtf 0001178913-19-002920.xls 0001178913-19-002920.pdf
Dec 13, 2019	CT ORDER	CT ORDER	9999999997-19-007877.pdf
Dec 05, 2019	6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	0001178913-19-002894.rtf 0001178913-19-002894.xls 0001178913-19-002894.pdf

Data provided by Kaleidoscope.